Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein
- PMID: 18983676
- PMCID: PMC2637266
- DOI: 10.1186/1756-6606-1-15
Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein
Abstract
Background: Deposition of amyloid-β protein (Aβ) is a major pathological hallmark of Alzheimer's disease (AD). Aβ is generated from γ-secretase cleavage of amyloid precursor protein (APP). In addition to APP, γ-secretase also cleaves other type I integral membrane proteins, including the Notch receptor, a key molecule involved in embryonic development.
Results: To explore selective γ-secretase inhibitors, a combination of five methods was used to systematically determine these inhibitors' profiles on the γ-secretase cleavage of APP and Notch. When two potent γ-secretase inhibitors, compound E (cpd E) and DAPT, were used in a conventional in vitro γ-secretase activity assay, cpd E completely blocked Aβ generation from the cleavage of substrate APP C100, but only had a minor effect on Notch cleavage and NICD generation. Next, cpd E and DAPT were applied to HEK293 cells expressing a truncated Notch substrate NotchDeltaE. Both cpd E and DAPT were more potent in blocking Aβ generation than NICD generation. Third, a reporter construct was created that carried the NICD targeting promoter with three Su(H) binding sequences followed by the luciferase gene. We found that the inhibition of NICD generation by cpd E and DAPT was consistent with the reduced expression of luciferase gene driven by this Notch targeting promoter. Fourth, levels of "Notch-Aβ-like" (Nβ*) peptide derived from two previously reported chimeric APP with its transmembrane domain or the juxtamembrane portion replaced by the Notch sequence were quantified. Measurement of Nβ* peptides by ELISA confirmed that EC₅₀'s of cpd E were much higher for Nβ* than Aβ. Finally, the expression levels of Notch target gene her6 in cpd E or DAPT-treated zebrafish were correlated with the degree of tail curvature due to defective somitogenesis, a well characterized Notch phenotype in zebrafish.
Conclusion: Our ELISA-based quantification of Aβ and Nβ* in combination with the test in zebrafish provides a novel approach for efficient cell-based screening and in vivo validation of APP selective γ-secretase inhibitors.
Figures





Similar articles
-
Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors.BMC Biotechnol. 2010 Mar 22;10:24. doi: 10.1186/1472-6750-10-24. BMC Biotechnol. 2010. PMID: 20307292 Free PMC article.
-
Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.Biochemistry. 2003 Jun 24;42(24):7580-6. doi: 10.1021/bi034310g. Biochemistry. 2003. PMID: 12809514
-
Proton myo-inositol cotransporter is a novel γ-secretase associated protein that regulates Aβ production without affecting Notch cleavage.FEBS J. 2015 Sep;282(17):3438-51. doi: 10.1111/febs.13353. Epub 2015 Jul 14. FEBS J. 2015. PMID: 26094765 Review.
-
An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.Biochemistry. 2009 Nov 24;48(46):10894-904. doi: 10.1021/bi901237k. Biochemistry. 2009. PMID: 19821615 Free PMC article.
-
The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer's Disease.Curr Drug Discov Technol. 2014;11(4):243-58. doi: 10.2174/1570163811666141121101358. Curr Drug Discov Technol. 2014. PMID: 25413946 Review.
Cited by
-
Notch intracellular domain regulates glioblastoma proliferation through the Notch1 signaling pathway.Oncol Lett. 2021 Apr;21(4):303. doi: 10.3892/ol.2021.12564. Epub 2021 Feb 19. Oncol Lett. 2021. PMID: 33732379 Free PMC article.
-
Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.PLoS One. 2016 Sep 29;11(9):e0163072. doi: 10.1371/journal.pone.0163072. eCollection 2016. PLoS One. 2016. PMID: 27684569 Free PMC article.
-
Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors.BMC Biotechnol. 2010 Mar 22;10:24. doi: 10.1186/1472-6750-10-24. BMC Biotechnol. 2010. PMID: 20307292 Free PMC article.
-
Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.J Neurosci. 2011 Jun 29;31(26):9513-25. doi: 10.1523/JNEUROSCI.0858-11.2011. J Neurosci. 2011. PMID: 21715616 Free PMC article.
-
γ-Secretase inhibition promotes fibrotic effects of albumin in proximal tubular epithelial cells.Br J Pharmacol. 2013 Jul;169(6):1239-51. doi: 10.1111/bph.12214. Br J Pharmacol. 2013. PMID: 23594166 Free PMC article.
References
-
- Selkoe DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med. 2004;140:627–638. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases